Covered recipient · General Payments record
TROY L CARTER
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$6,132.01
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,000.00 | 1 |
| Food and Beverage | $355.59 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $2,000.00 | 1 |
| Bausch & Lomb Americas Inc. | $103.98 | 1 |
| ABBVIE INC. | $100.47 | 4 |
| Ocular Therapeutix, Inc. | $55.63 | 3 |
| BIOTISSUE HOLDINGS INC. | $49.15 | 3 |
| Astellas Pharma US Inc | $27.07 | 1 |
| Amgen Inc. | $19.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $2,000.00 | 11/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125398864 | CMS |
| ABBVIE INC. | $30.75 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103423579 | CMS |
| ABBVIE INC. | $23.93 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103423581 | CMS |
| ABBVIE INC. | $23.93 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103423583 | CMS |
| ABBVIE INC. | $21.86 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103423585 | CMS |
| Amgen Inc. | $19.29 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115483881 | CMS |
| Astellas Pharma US Inc | $27.07 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139450744 | CMS |
| Bausch & Lomb Americas Inc. | $103.98 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140462796 | CMS |
| BIOTISSUE HOLDINGS INC. | $13.25 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148757353 | CMS |
| BIOTISSUE HOLDINGS INC. | $17.95 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148783293 | CMS |
| BIOTISSUE HOLDINGS INC. | $17.95 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148760513 | CMS |
| Ocular Therapeutix, Inc. | $21.64 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148204083 | CMS |
| Ocular Therapeutix, Inc. | $17.16 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148204087 | CMS |
| Ocular Therapeutix, Inc. | $16.83 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148204085 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.